10x Genomics, Inc. Class A Common Stock (NASDAQ: TXG) last traded at $65.12, up 1.96% on the session. The quote above updates while this page is open; the figures below are drawn from 10x Genomics, Inc. Class A Common Stock’s own filings and are restated only when a new one is published.
10x Genomics, Inc. Class A Common Stock trades on NASDAQ under the ticker TXG. Its market capitalisation is $8.32 billion.
Valuation measures for 10x Genomics, Inc. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $8.32B |
|---|---|
| Price / sales | 13.48 |
| Price / book | 10.07 |
| Beta | 2.24 |
Trailing-twelve-month figures tagged in 10x Genomics, Inc. Class A Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $616.91M |
|---|---|
| Net income (TTM) | -$75.13M |
| EPS (TTM) | -$0.590 |
| Gross margin | 70.03% |
| Operating margin | -14.33% |
| Return on equity | -9.10% |
Range and volume for TXG over the past 52 weeks.
| 52-week high | $65.47 |
|---|---|
| 52-week low | $11.16 |
| Volume | 3.14M |
| Average volume | 3.26M |
| Previous close | $63.87 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.